Hald, J. D. et al. (2026) Teriparatide plus zoledronic acid for osteogenesis imperfecta: a randomized clinical trial. Journal of the American Medical Association, 336(2), pp. 116-124. (doi: 10.1001/jama.2026.6889) Full text not currently available from Enlighten. Abstract IMPORTANCE: Osteogenesis imperfecta causes multiple fractures throughout life, causing substantial morbidity.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile